Dynavax Technologies | Profitto Lordo Sulle Vendite

Gross Profit On Sales Cambiamento Data
Adma Biologics USD 31.09M 6.43M 2023-12
Amgen USD 5.08B 14M 2023-12
AstraZeneca USD 9.43B 15M 2023-09
Dynavax Technologies USD 46.91M 9.38M 2023-12
Gilead Sciences USD 5.5B 18M 2023-12
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
Pfizer USD 7.58B 3.26B 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Roche Holding CHF 22.16B 123M 2023-06
Sarepta Therapeutics USD 294.79M 67.68M 2023-09
TG Therapeutics USD 36.12M 126.19M 2023-12
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09



Dynavax Technologies Profitto Lordo Sulle Vendite - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.